Inari Medical to acquire LimFlow for up to $415M

Inari Medical has agreed to acquire LimFlow, a maker of a limb-saving device for chronic limb-threatening ischemia, for $250 million in cash upfront plus up to $165 million in milestone payments. The transaction is expected to close in Q4 2023.

“We think this is a smart, timely buy of a pioneering, much-needed technology.”medtechdive.com

• 1 source
• medtechdive.comInari Medical to buy limb-saving device maker LimFlow for up to $415M | MedTech DiveSusan KellyNov 3, 2023

Summarized from public sources; check the original articles before acting on it.